These data suggest that the role of hENT1 as main mediator of gemcitabine across plasma membrane could be also affected from expression of MRP1 in PDAC tumor tissues, directly or as result of CHOP transcriptional regulation. The gene discussed is DDIT3; the disease is neoplasm.